Abstract

Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of a checklist of information to include in publications describing in vivo experiments to enable others to scrutinise the work adequately, evaluate its methodological rigour, and reproduce the methods and results. Despite considerable levels of endorsement by funders and journals over the years, adherence to the guidelines has been inconsistent, and the anticipated improvements in the quality of reporting in animal research publications have not been achieved. Here, we introduce ARRIVE 2.0. The guidelines have been updated and information reorganised to facilitate their use in practice. We used a Delphi exercise to prioritise and divide the items of the guidelines into 2sets, the 'ARRIVE Essential 10,' which constitutes the minimum requirement, and the 'Recommended Set,' which describes the research context. This division facilitates improved reporting of animal research by supporting a stepwise approach to implementation. This helps journal editors and reviewers verify that the most important items are being reported in manuscripts. We have also developed the accompanying Explanation and Elaboration document, which serves (1) to explain the rationale behind each item in the guidelines, (2) to clarify key concepts, and (3) to provide illustrative examples. We aim, through these changes, to help ensure that researchers, reviewers, and journal editors are better equipped to improve the rigour and transparency of the scientific process and thus reproducibility.

Highlights

  • ResultsProvide brief details of study design including:. (a) The groups being compared, including control groups

  • Provide an accurate summary of the research objectives, animal species, strain and sex, key methods, principal findings, and study conclusions.(a) Include sufficient scientific background to understand the rationale and context for the study, and explain the experimental approach.(b) Explain how the animal species and model used address the scientific objectives and, where appropriate, the relevance to human biology

  • We have developed the accompanying Explanation and Elaboration document, which serves (1) to explain the rationale behind each item in the guidelines, (2) to clarify key concepts, and (3) to provide illustrative examples

Read more

Summary

Results

Provide brief details of study design including:. (a) The groups being compared, including control groups. Provide brief details of study design including:. (a) Specify the exact number of experimental units allocated to each group, and the total number in each experiment. (a) Describe any criteria used for including and excluding animals (or experimental units) during the experiment, and data points during the analysis. Specify if these criteria were established a priori. (b) For each experimental group, report any animals, experimental units, or data points not included in the analysis and explain why. (a) State whether randomisation was used to allocate experimental units to control and treatment groups. (a) Provide details of the statistical methods used for each analysis, including software used.

Background
Ethical statement
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call